NUROFEN IN RECTAL SUPPOSITORIES IN FEBRILE CHILREN

Download full text PDF
Issue: 
1
Year: 
2015

T. Potupchik (1), Candidate of Medical Sciences; O. Veselova (1), Candidate of Medical Sciences; L. Evert (2), MD 1 -Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2 -Research Institute for Medical Problems of the North, Krasnoyarsk

The paper gives the main features and advantages of ibuprofen (Nurofen) as rectal suppositories over acetaminophen (Paracetamol) in young children with acute respiratory viral infections accompanied by hyperthermia; Nurofen suppositories provide a more pronounced and prolonged antipyretic effect, abolish fever 1.2 times more promptly, and have a higher safety profile.
Keywords: 
acute respiratory viral infections
infants
Nurofen

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Geppe N.A., Ozerskaja I.V. Ibuprofen – mesto v taktike zharoponizhaju schej terapii u detej // Pediatrija. – 2013; 2: 107–11.
  2. Geppe N.A. Pervaja Mezhdunarodnaja konferentsija po primeneniju ibu-profena v pediatrii // Ros. med. zhurn. – 2002; 18 (162): – 831–5.
  3. Zaharova I.N., Zaplatnikov A.L., Tvorogova T.M. i dr. Osobennosti vybora zharoponizhajuschih sredstv u detej s allergicheskimi zabolevanijami // Rus. med. zhurn. – 2014; 3: 220–4.
  4. Zaharova I.N., Tvorogova T.M. Primenenie zharoponizhajuschih preparatov pri lihoradke u detej // Voprosy prakticheskoj pediatrii. – 2013; 8 (1): 63–6.
  5. Korovina N.A., Zaplatnikov A.L., Zaharova I.N. i dr. Febril'nye sudorogi i ratsional'noe primenenie zharoponizhajuschih lekarstvennyh sredstv u detej // Voprosy sovremennoj pediatrii. – 2004; 3 (5): 112–7.
  6. Kljuchnikov S.O. Lihoradka i primenenie zharoponizhajuschih preparatov u detej // Pediatrija. – 2012; 91 (4): 121–5.
  7. Lokshina E.E., Zajtseva O.V., Keshishjan E.S. i dr. Ispol'zovanie zharoponizhajuschih preparatov u detej s ostrymi respiratornymi infektsijami // Pediatrija. – 2010; 89 (2): 113–9.
  8. Ushkalova E.A. Profil' bezopasnosti anal'getikov-antipiretikov v pediatrii // Rus. med. zhurn. – 2014; 21: 1526–9.
  9. Shajtor V.M. Zharoponizhajuschie sredstva pri lihoradke u detej // Farmateka. – 2011; 1–11: 28–32.
  10. Autret-Leca E. A general overview of the use of ibuprofen in paediatrics // Int J Clin Pract Suppl. – 2003; 135: 9–12.
  11. utret-Leca E., Gibb I., Goulder M. Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized blinded study // Curr. Med. Res. Opin. – 2007; 23: 2205–11.
  12. Brune K., Hinz B., Otterness I. Aspirin and acetaminophen: should they be available over the counter? // Curr. Rheumatol. Rep. – 2009; 11 (1): 36–40.
  13. Del Rosso J., Kircik L. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolonepivalate 0.1% cream // J. Drugs Dermatol. – 2014; 13 (7): 77–83.
  14. Hay A., Costelloe C., Redmond N. Paracetamol plus ibuprofen for the treatment of fever in children: randomised controlled trial // BMJ. – 2008; 337: 729–33.
  15. Haywood A. Pharmaceutical excipients – where do we begin? // Aust. Prescr. – 2011; 34: 112–4.King J., Davis T., Bailey S. et al. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen // Am. J. Prev. Med. – 2011; 40 (6): 593–8.
  16. Larrey D., Pageaux G. Genetic predisposition to drug-induced hepatotoxicity // J. Hepatol. – 1997; 26 (Suppl. 2): 12–21
  17. Lundstrom K. Ibuprofen is more effective than paracetamol in lowering the temperature in febrile children // Ugeskr. Laeger. – 2012; 174 (18): 1214–7.
  18. Maguire T. Ibuprofen: a model medicine for self-care of common conditions // Int. J. Clin. Pract. Suppl. – 2013; 178: 43–6.
  19. Martinez-Gimeno A., Garcia-Marcos L. The association between acetaminophen and asthma: should its pediatric use be banned? // Expert Rev. Respir. Med. – 2013; 7 (2): 113–22.
  20. Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management // J. Med. Toxicol. – 2008; 4 (1): 2–6.
  21. Rainsford K. Ibuprofen: pharmacology, efficacy and safety // Inflammopharmacology. – 2009; 17 (6): 275–342.
  22. Pawar S., Kumar A. Issues in the formulation of drugs for oral use children: role of excipients // Paediatr. Drugs. – 2002; 4 (6): 371–9.
  23. Sauerwein R., Mulder J., Mulder L. et al. Inflammatory mediators in children with protein-energy malnutrition // Am. J. Clin. Nutr. – 1997; 65: 1534–9.
  24. Savino F., Lupica M., Tarasco V. et al. Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant // Pediatrics. – 2011; 127 (2): 494–7.
  25. Song B., Veech R., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics // J. Clin. Endocrinol. Metab. – 1990; 71: 1036–40.
  26. Squires R.-Jr., Shneider B., Bucuvalas J. et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group // J. Pediatr. – 2006; 148 (5): 652–8.
  27. Turner M., Duncan J., Shah U. et al. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas // Adv. Drug. Deliv. Rev. – 2014; 73 (89): 101.
  28. Zhang W., Parentau H., Greenly R. et al. Effect of protein-calorie malnutrition 29. on cytochromes P450 and glutathione S-transferase // Eur. J. Drug. Metab. Pharmacokinet. – 1999; 24: 141–7.
  29. Shaoul R., Novikov J., Maor I. et al. Silent acetaminophen-induced 30. hepatotoxicity in febrile children: does this entity exist? // Acta Paediatr. – 2004; 93 (5): 618–22.
  30. O'Shea D., Davis S., Kim R. et al. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity // Clin. Pharmacol. Ther. – 1994; 56: 359–67.NUR